Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash & Current Investments: 2013-2025

Historic Cash & Current Investments for MediWound (MDWD) over the last 13 years, with Sep 2025 value amounting to $32.7 million.

  • MediWound's Cash & Current Investments rose 405.59% to $32.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 742.79%. This contributed to the annual value of $9.2 million for FY2024, which is 22.85% down from last year.
  • According to the latest figures from Q3 2025, MediWound's Cash & Current Investments is $32.7 million, which was up 504.36% from -$8.1 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Cash & Current Investments registered a high of $51.0 million during Q1 2023, and its lowest value of -$31.9 million during Q2 2023.
  • For the 3-year period, MediWound's Cash & Current Investments averaged around $5.2 million, with its median value being $6.5 million (2024).
  • In the last 5 years, MediWound's Cash & Current Investments tumbled by 512.14% in 2023 and then skyrocketed by 405.59% in 2025.
  • Over the past 5 years, MediWound's Cash & Current Investments (Quarterly) stood at $11.0 million in 2021, then skyrocketed by 206.85% to $33.9 million in 2022, then crashed by 64.99% to $11.9 million in 2023, then dropped by 22.85% to $9.2 million in 2024, then surged by 405.59% to $32.7 million in 2025.
  • Its Cash & Current Investments stands at $32.7 million for Q3 2025, versus -$8.1 million for Q2 2025 and -$7.8 million for Q1 2025.